Buy this Article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Aschenbrenner, Diane S. MA, RN

Abstract

* Flibanserin (Addyi) is the first drug approved to treat hypoactive sexual desire disorder. It is approved for use only in premenopausal women and must be taken nightly.

 

* In clinical trials flibanserin treatment increased the number of satisfying sexual events by one-half to one event per month over placebo.

 

* Alcohol use is contraindicated when taking flibanserin because it can cause significant hypotension and syncope. Significant drug-drug interactions are also possible.